Issued by Citigate Dewe Rogerson Limited, Birmingham
Date: 7 November 2008
Dechra® Pharmaceuticals PLC
(the 'Company' or the 'Group')
Results of Annual General Meeting ('AGM')
Dechra Pharmaceuticals PLC announces that all resolutions proposed at its AGM held on 7 November 2008 were duly passed on a show of hands.
Copies of the following:
Ordinary resolution adopting the Dechra Long Term Incentive Plan 2008;
Ordinary resolution approving the amendments to the Dechra Pharmaceuticals Approved Share Option Scheme;
Ordinary resolution approving the amendments to the Dechra Pharmaceuticals Unapproved Share Option Scheme;
Ordinary resolution relating to the renewal of the authority for the directors to allot new shares;
Special resolution relating to the renewal of the authority for the directors to disapply pre-emption rights;
Special resolution relating to the renewal of the authority for the Company to purchase its own shares; and
Special resolution relating to the adoption of new Articles of Association,
being resolutions (other than resolutions concerning ordinary business) passed by the Company at its AGM on 7 November 2008, will be submitted to the UK Listing Authority and will thereafter be available for publication at the UK Listing Authority's Document Viewing Facility which is situated at :
Financial Services Authority
25 The North Colonnade
Canary Wharf
London E14 5HS
Tel : 020 7066 1000
Details of the proxy voting instructions lodged prior to the AGM are set out below:
Resolution (No. as noted on proxy form) |
For |
Against |
Discretionary |
Withheld |
Resolution 1: To receive and consider report and accounts |
40,583,352 |
0 |
12,918 |
208 |
Resolution 2: To receive and approve the Directors Remuneration Report |
39,533,536 |
733,072 |
12,918 |
316,952 |
Resolution 3: To declare a final dividend |
40,583,352 |
0 |
12,918 |
208 |
Resolution 4: To re-elect Ian Page |
40,555,971 |
27,589 |
12,918 |
0 |
Resolution 5: To re-elect Neil Warner |
40,434,449 |
148,903 |
12,918 |
208 |
Resolution 6: To re-appoint KPMG Audit plc as Auditors and to authorise the directors to fix their remuneration |
40,293,715 |
289,845 |
12,918 |
0 |
Resolution 7: To approve the adoption of the LTIP |
39,430,332 |
1,153,020 |
12,918 |
208 |
Resolution 8: To approve the amendments to the Dechra Pharmaceuticals PLC Approved Share Option Scheme |
40,476,190 |
18,550 |
13,070 |
88,668 |
Resolution 9: To approve the amendments to the Dechra Pharmaceuticals PLC Unapproved Share Option Scheme |
40,476,190 |
18,550 |
13,070 |
88,668 |
Resolution 10: To grant authority to allot equity securities |
40,581,578 |
1,830 |
13,070 |
0 |
Resolution 11: To renew authority for pre-emptive allotment of equity securities |
40,579,698 |
3,294 |
13,278 |
208 |
Resolution 12: To grant authority to the Company to purchase ordinary shares |
40,581,034 |
2,318 |
12,918 |
208 |
Resolution 13: To adopt New Articles of Association |
40,581,522 |
1,830 |
12,918 |
208 |
Enquiries:
|
|
|
Zoe Bamford, Company Secretary
|
Dechra Pharmaceuticals PLC
|
Tel: +44 (0) 1782 771100
|
Dechra and the Dechra 'D' logo are registered Trademarks of Dechra Pharmaceuticals PLC